πŸ‡ΊπŸ‡Έ FDA
Patent

US 11608501

Methods for modifying RNA splicing

granted A61KA61K31/433A61K31/454

Quick answer

US patent 11608501 (Methods for modifying RNA splicing) held by PTC THERAPEUTICS, INC. expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Mar 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/433, A61K31/454, A61K31/501